Clinical Trial of Tolcapone for Cognition in Schizophrenia
Condition(s):SchizophreniaLast Updated:September 27, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:September 27, 2018Terminated
Condition(s):Alcohol Use Disorder; Attention Deficit Hyperactivity DisorderLast Updated:March 4, 2024Recruiting
Condition(s):Frontotemporal Lobar DegenerationLast Updated:August 19, 2019Completed
Condition(s):Pathological GamblingLast Updated:February 16, 2021Completed
Condition(s):Impulsive BehaviorLast Updated:November 20, 2020Completed
Condition(s):Nicotine DependenceLast Updated:November 24, 2020Completed
Condition(s):Brain Injuries; Brain Injuries, Traumatic; Brain Injury, ChronicLast Updated:September 6, 2017Unknown status
Condition(s):Tobacco Use DisorderLast Updated:July 2, 2014Completed
Condition(s):Cocaine-Related DisordersLast Updated:January 11, 2017Unknown status
Condition(s):Familial Amyloid Polyneuropathy (FAP)Last Updated:November 30, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.